Published in Int J Urol on November 19, 2012
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra. Ann Oncol (2015) 1.04
Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense? World J Urol (2016) 0.84
A comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancer. Biomed Res Int (2014) 0.82
Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer. Front Oncol (2013) 0.80
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab (2009) 2.87
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res (2012) 1.65
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget (2010) 1.53
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA (2011) 1.36
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res (2005) 1.25
Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res (2005) 1.18
Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet (2013) 1.18
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer (2006) 1.17
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate (2010) 1.15
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res (2005) 1.14
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun (2007) 1.09
Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol (2010) 1.09
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res (2005) 1.09
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer (2005) 1.06
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res (2004) 1.05
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res (2006) 0.96
Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate (2013) 0.95
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther (2012) 0.94
Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog (2007) 0.94
miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol (2014) 0.93
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J (2012) 0.93
Comparison of open surgery versus retroperitoneoscopic approach to chyluria. J Urol (2003) 0.92
Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation (2008) 0.91
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids (2012) 0.91
Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases. Urology (2005) 0.89
miRNA goes nuclear. RNA Biol (2012) 0.87
An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment. J Vis Exp (2012) 0.87
Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Urol Int (2008) 0.86
Retroperitoneoscopic subcapsular nephrectomy for infective nonfunctioning kidney with dense perinephric adhesions. BJU Int (2004) 0.84
Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol (2005) 0.84
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog (2002) 0.84
Small RNA and its application in andrology and urology. Transl Androl Urol (2012) 0.84
MicroRNA regulation of neuron-like differentiation of adipose tissue-derived stem cells. Differentiation (2009) 0.82
Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol (2003) 0.81
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol (2013) 0.79
RNAa in action: from the exception to the norm. RNA Biol (2014) 0.78
Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol (2004) 0.78
Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun (2002) 0.75